Expansion of R&D center and office

Seongsoo HQ open

Awarded “Team Korea: Innovative Company 1000”

Awarded “Minister Award for Excellent Outcome: IP R&D”

Awarded “Seoul Tech-employee Support for Excellent Startup”

Joint R&D Agreement with Yungjin Pharm for Parkinson’s disease research

New Office opened in Daehak-ro, Jongno-gu, Seoul

Series A financing

Selected as a Baby-Unicorn under K-Unicorn 200 project (Ministry of SMEs and Startups)

IP-R&D (KISTA) support program

MOU with YUNGJIN Pharmaceuticals for Parkinson’s disease research

MOU with Aptamer Sciences for Parkinson’s disease research

Seed fund raising

Acquisition of Tomaralimab from Opsona (Global rights for the development and commercialization of current and future indications)

Joint R&D Agreement with Amyloid Solution

IP-R&D (KISTA) support program

Fund raising through TIPS (Tech Incubator Program for Startup, CCEI)

Founded